<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: The aim of this study was to determine whether telomere length is an independent prognostic factor for the prevention and survival of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHOD: Terminal restriction fragment (TRF) length was determined by Southern blot in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> and paired <z:mpath ids='MPATH_458'>normal</z:mpath> tissue samples from 147 patients with <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> who had undergone surgery </plain></SENT>
<SENT sid="2" pm="."><plain>The TRF length ratio (TRFLR) was determined as the ratio between the length of the patient's <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> and <z:mpath ids='MPATH_458'>normal</z:mpath> tissue.The classification and regression tree technique was used to determine optimal cut-off values (≤ 1 or &gt; 1) </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Mean TRF length was 6.79 Kbp (1.19-13.99) in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> tissue and 7.81 Kbp (3.63-15.70) in <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa (P &lt; 0.001) </plain></SENT>
<SENT sid="4" pm="."><plain>Mean TRFLR was 0.88 </plain></SENT>
<SENT sid="5" pm="."><plain>Telomere length and telomere length ratio were not correlated with any clinicopathological factors </plain></SENT>
<SENT sid="6" pm="."><plain>In univariate analysis, overall survival was related to N stage (lymph node +/-; P = 0.002), TNM classification (P = 0.019) and TRFLR (≤ 1 or &gt; 1; P = 0.014) </plain></SENT>
<SENT sid="7" pm="."><plain>In multivariate analysis, overall survival was significantly associated with TRFLR and N stage </plain></SENT>
<SENT sid="8" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> patients with TRFLR ≤ 1 and negative lymph node involvement had a higher overall survival rate </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: Telomere length ratio is an independent prognostic factor for survival in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients, and the telomere lengths in the <z:mpath ids='MPATH_458'>normal</z:mpath> and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> mucosa of the same patient present with parallel behaviour </plain></SENT>
</text></document>